Skip to Content

Histrelin

In the US, Histrelin (histrelin systemic) is a member of the following drug classes: gonadotropin releasing hormones, hormones/antineoplastics and is used to treat Precocious Puberty and Prostate Cancer.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L02AE05

CAS registry number (Chemical Abstracts Service)

0076712-82-8

Chemical Formula

C66-H86-N18-O12

Molecular Weight

1323

Therapeutic Categories

Antineoplastic agent

Gonadotropin releasing hormone (GnRH) agonist

Chemical Name

5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-N²-benzyl-D-histidyl-L-leucyl-L-arginyl-N-etyl-L-prolinamide (WHO)

Foreign Names

  • Histrelinum (Latin)
  • Histrelin (German)
  • Histréline (French)
  • Histrelina (Spanish)

Generic Names

  • Histrelin (OS: USAN)
  • ORF 17070 (IS: Ortho)
  • RWJ 17070 (IS)

Brand Names

  • Vantas
    Orion, Lithuania; Orion, Latvia; Orion, Slovenia; Tuteur, Argentina
  • Supprelin LA
    Endo, United States
  • Vantas
    Endo, United States; Orion, Czech Republic; Orion, Spain; Orion, Ireland; Orion, Portugal; Orion Pharma, Germany
  • Vantasse
    Orion, Netherlands

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide